English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Physical literacy-based intervention for older adults: a cluster randomized controlled trial study protocol Journal article
SUM RAYMOND KIM WAI, Yang Yijian, CHOI SIU MING, Michael J. Duncan, LI MINGHUI. Physical literacy-based intervention for older adults: a cluster randomized controlled trial study protocol[J]. Frontiers in Sports and Active Living, 2024, 6, 1392270.
Authors:  SUM RAYMOND KIM WAI;  Yang Yijian;  CHOI SIU MING;  Michael J. Duncan;  LI MINGHUI
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/08/08
Physical Literacy  Older Adults  Randomized Clinical Trial  Study Protocol  Hong Kong  
hESC-derived MSCs for clinical trials, developmental study, and cancer research Presentation
会议地点: Guiyang, 会议日期: 2024-07, 报告日期: 2024-07-01
Authors:  XU REN HE
Favorite |  | Submit date：2024/07/17
Hesc-derived Mscs, Clinical Trials, Developmental Study, Cancer Research  
Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study Journal article
Wu, Sijia, Zhang, Siyuan, Peng, Bo, Tan, Dechao, Wu, Mingyue, Wei, Jin Chao, Wang, Yi Tao, Luo, Hua. Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study[J]. Food Science and Human Wellness, 2024, 13(2), 568-596.
Authors:  Wu, Sijia;  Zhang, Siyuan;  Peng, Bo;  Tan, Dechao;  Wu, Mingyue; et al.
Favorite | TC[WOS]:0 TC[Scopus]:29  IF:5.6/6.8 | Submit date：2024/04/02
Clinical Study  Efficacy  Ganoderma Lucidum  Phytochemistry  Safety  
Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies Review article
2021
Authors:  Yang,Yuhan;  Vong,Chi Teng;  Zeng,Shan;  Gao,Caifang;  Chen,Zhejie; et al.
Favorite | TC[WOS]:27 TC[Scopus]:29  IF:4.8/4.8 | Submit date：2021/03/02
Berberine  Clinical Study  Coptis Chinensis  Inflammatory Bowel Disease  Pharmacokinetics  Pharmacology  Review  
Dietary polyphenols as antidiabetic agents: Advances and opportunities Review article
2020
Authors:  Sun, Chongde;  Zhao, Chao;  Guven, Esra Capanoglu;  Paoli, Paolo;  Simal-Gandara, Jesus; et al.
Favorite | TC[WOS]:205 TC[Scopus]:229 | Submit date：2023/04/13
Bioavailability  Clinical Study  Diabetes  Diabetic Complication  Dietary Polyphenols  Glucose Absorption  Intestinal Microbiota  Pancreatic Islet Β-cell  
Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial Review article
2019
Authors:  Hui Cao;  Juanying Ou;  Lei Chen;  Yanbo Zhang;  Tomasz Szkudelski; et al.
Favorite | TC[WOS]:203 TC[Scopus]:220  IF:7.3/10.3 | Submit date：2022/05/17
Clinical Trial  Dietary Polyphenols  Human Study  Type 2 Diabetes  
Estimating the “First in human” dose – a revisit with particular emphases in oncology drugs Journal article
Tam, K. Y.. Estimating the “First in human” dose – a revisit with particular emphases in oncology drugs[J]. ADMET & DMPK, 2013, 63-75.
Authors:  Tam, K. Y.
Favorite | TC[WOS]:14 TC[Scopus]:15  IF:3.4/2.8 | Submit date：2022/07/27
Initial Dose  Starting Dose  Clinical Trial  Noael  Mabel  Cytotoxic  Anticancer  Combination Therapy Study  
Estimating the “First in human” dose – a revisit with particular emphasis on oncology drugs Journal article
Kin Tam. Estimating the “First in human” dose – a revisit with particular emphasis on oncology drugs[J]. ADMET & DMPK, 2013, 1(4), 63-75.
Authors:  Kin Tam
Favorite | TC[WOS]:14 TC[Scopus]:15  IF:3.4/2.8 | Submit date：2019/01/07
Initial Dose  Starting Dose  Clinical Trial  Noael  Mabel  Cytotoxic  Anticancer  Combination Therapy Study